Business Description
Microba Life Sciences Ltd
ISIN : AU0000209868
Description
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers. The company's segment includes Testing Services, and Research and Development.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.34 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.9 | |||||
| 9-Day RSI | 54.02 | |||||
| 14-Day RSI | 51.45 | |||||
| 6-1 Month Momentum % | -6.67 | |||||
| 12-1 Month Momentum % | -28.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.27 | |||||
| Quick Ratio | 3.11 | |||||
| Cash Ratio | 2.16 | |||||
| Days Inventory | 86.06 | |||||
| Days Sales Outstanding | 304.48 | |||||
| Days Payable | 342.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 29.49 | |||||
| Operating Margin % | -406.04 | |||||
| Net Margin % | -282.62 | |||||
| FCF Margin % | -354.43 | |||||
| ROE % | -41.65 | |||||
| ROA % | -33.86 | |||||
| ROIC % | -167.88 | |||||
| ROC (Joel Greenblatt) % | -511.79 | |||||
| ROCE % | -40.36 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.28 | |||||
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 2.64 | |||||
| EV-to-EBIT | -3.04 | |||||
| EV-to-Forward-EBIT | -3.43 | |||||
| EV-to-EBITDA | -3.39 | |||||
| EV-to-Forward-EBITDA | -3.53 | |||||
| EV-to-Revenue | 8.59 | |||||
| EV-to-Forward-Revenue | 6.37 | |||||
| EV-to-FCF | -2.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.08 | |||||
| Price-to-Net-Cash | 6.17 | |||||
| Earnings Yield (Greenblatt) % | -32.89 | |||||
| FCF Yield % | -27.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Microba Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 6.542 | ||
| EPS (TTM) (A$) | -0.05 | ||
| Beta | 0 | ||
| Volatility % | 50.23 | ||
| 14-Day RSI | 51.45 | ||
| 14-Day ATR (A$) | 0.010106 | ||
| 20-Day SMA (A$) | 0.18175 | ||
| 12-1 Month Momentum % | -28.22 | ||
| 52-Week Range (A$) | 0.15 - 0.424687 | ||
| Shares Outstanding (Mil) | 447.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Microba Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Microba Life Sciences Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Microba Life Sciences Ltd Frequently Asked Questions
What is Microba Life Sciences Ltd(ASX:MAP)'s stock price today?
The current price of ASX:MAP is A$0.19. The 52 week high of ASX:MAP is A$0.42 and 52 week low is A$0.15.
When is next earnings date of Microba Life Sciences Ltd(ASX:MAP)?
The next earnings date of Microba Life Sciences Ltd(ASX:MAP) is .
Does Microba Life Sciences Ltd(ASX:MAP) pay dividends? If so, how much?
Microba Life Sciences Ltd(ASX:MAP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers